700 related articles for article (PubMed ID: 21163964)
1. The genetic landscape of the childhood cancer medulloblastoma.
Parsons DW; Li M; Zhang X; Jones S; Leary RJ; Lin JC; Boca SM; Carter H; Samayoa J; Bettegowda C; Gallia GL; Jallo GI; Binder ZA; Nikolsky Y; Hartigan J; Smith DR; Gerhard DS; Fults DW; VandenBerg S; Berger MS; Marie SK; Shinjo SM; Clara C; Phillips PC; Minturn JE; Biegel JA; Judkins AR; Resnick AC; Storm PB; Curran T; He Y; Rasheed BA; Friedman HS; Keir ST; McLendon R; Northcott PA; Taylor MD; Burger PC; Riggins GJ; Karchin R; Parmigiani G; Bigner DD; Yan H; Papadopoulos N; Vogelstein B; Kinzler KW; Velculescu VE
Science; 2011 Jan; 331(6016):435-9. PubMed ID: 21163964
[TBL] [Abstract][Full Text] [Related]
2. Aberrant patterns of H3K4 and H3K27 histone lysine methylation occur across subgroups in medulloblastoma.
Dubuc AM; Remke M; Korshunov A; Northcott PA; Zhan SH; Mendez-Lago M; Kool M; Jones DT; Unterberger A; Morrissy AS; Shih D; Peacock J; Ramaswamy V; Rolider A; Wang X; Witt H; Hielscher T; Hawkins C; Vibhakar R; Croul S; Rutka JT; Weiss WA; Jones SJ; Eberhart CG; Marra MA; Pfister SM; Taylor MD
Acta Neuropathol; 2013 Mar; 125(3):373-84. PubMed ID: 23184418
[TBL] [Abstract][Full Text] [Related]
3. Medulloblastoma exome sequencing uncovers subtype-specific somatic mutations.
Pugh TJ; Weeraratne SD; Archer TC; Pomeranz Krummel DA; Auclair D; Bochicchio J; Carneiro MO; Carter SL; Cibulskis K; Erlich RL; Greulich H; Lawrence MS; Lennon NJ; McKenna A; Meldrim J; Ramos AH; Ross MG; Russ C; Shefler E; Sivachenko A; Sogoloff B; Stojanov P; Tamayo P; Mesirov JP; Amani V; Teider N; Sengupta S; Francois JP; Northcott PA; Taylor MD; Yu F; Crabtree GR; Kautzman AG; Gabriel SB; Getz G; Jäger N; Jones DT; Lichter P; Pfister SM; Roberts TM; Meyerson M; Pomeroy SL; Cho YJ
Nature; 2012 Aug; 488(7409):106-10. PubMed ID: 22820256
[TBL] [Abstract][Full Text] [Related]
4. Multiple recurrent genetic events converge on control of histone lysine methylation in medulloblastoma.
Northcott PA; Nakahara Y; Wu X; Feuk L; Ellison DW; Croul S; Mack S; Kongkham PN; Peacock J; Dubuc A; Ra YS; Zilberberg K; McLeod J; Scherer SW; Sunil Rao J; Eberhart CG; Grajkowska W; Gillespie Y; Lach B; Grundy R; Pollack IF; Hamilton RL; Van Meter T; Carlotti CG; Boop F; Bigner D; Gilbertson RJ; Rutka JT; Taylor MD
Nat Genet; 2009 Apr; 41(4):465-72. PubMed ID: 19270706
[TBL] [Abstract][Full Text] [Related]
5. Dissecting the genomic complexity underlying medulloblastoma.
Jones DT; Jäger N; Kool M; Zichner T; Hutter B; Sultan M; Cho YJ; Pugh TJ; Hovestadt V; Stütz AM; Rausch T; Warnatz HJ; Ryzhova M; Bender S; Sturm D; Pleier S; Cin H; Pfaff E; Sieber L; Wittmann A; Remke M; Witt H; Hutter S; Tzaridis T; Weischenfeldt J; Raeder B; Avci M; Amstislavskiy V; Zapatka M; Weber UD; Wang Q; Lasitschka B; Bartholomae CC; Schmidt M; von Kalle C; Ast V; Lawerenz C; Eils J; Kabbe R; Benes V; van Sluis P; Koster J; Volckmann R; Shih D; Betts MJ; Russell RB; Coco S; Tonini GP; Schüller U; Hans V; Graf N; Kim YJ; Monoranu C; Roggendorf W; Unterberg A; Herold-Mende C; Milde T; Kulozik AE; von Deimling A; Witt O; Maass E; Rössler J; Ebinger M; Schuhmann MU; Frühwald MC; Hasselblatt M; Jabado N; Rutkowski S; von Bueren AO; Williamson D; Clifford SC; McCabe MG; Collins VP; Wolf S; Wiemann S; Lehrach H; Brors B; Scheurlen W; Felsberg J; Reifenberger G; Northcott PA; Taylor MD; Meyerson M; Pomeroy SL; Yaspo ML; Korbel JO; Korshunov A; Eils R; Pfister SM; Lichter P
Nature; 2012 Aug; 488(7409):100-5. PubMed ID: 22832583
[TBL] [Abstract][Full Text] [Related]
6. Epigenetic Drivers in Pediatric Medulloblastoma.
Roussel MF; Stripay JL
Cerebellum; 2018 Feb; 17(1):28-36. PubMed ID: 29178021
[TBL] [Abstract][Full Text] [Related]
7. MLL4 Is Required to Maintain Broad H3K4me3 Peaks and Super-Enhancers at Tumor Suppressor Genes.
Dhar SS; Zhao D; Lin T; Gu B; Pal K; Wu SJ; Alam H; Lv J; Yun K; Gopalakrishnan V; Flores ER; Northcott PA; Rajaram V; Li W; Shilatifard A; Sillitoe RV; Chen K; Lee MG
Mol Cell; 2018 Jun; 70(5):825-841.e6. PubMed ID: 29861161
[TBL] [Abstract][Full Text] [Related]
8. Novel mutations target distinct subgroups of medulloblastoma.
Robinson G; Parker M; Kranenburg TA; Lu C; Chen X; Ding L; Phoenix TN; Hedlund E; Wei L; Zhu X; Chalhoub N; Baker SJ; Huether R; Kriwacki R; Curley N; Thiruvenkatam R; Wang J; Wu G; Rusch M; Hong X; Becksfort J; Gupta P; Ma J; Easton J; Vadodaria B; Onar-Thomas A; Lin T; Li S; Pounds S; Paugh S; Zhao D; Kawauchi D; Roussel MF; Finkelstein D; Ellison DW; Lau CC; Bouffet E; Hassall T; Gururangan S; Cohn R; Fulton RS; Fulton LL; Dooling DJ; Ochoa K; Gajjar A; Mardis ER; Wilson RK; Downing JR; Zhang J; Gilbertson RJ
Nature; 2012 Aug; 488(7409):43-8. PubMed ID: 22722829
[TBL] [Abstract][Full Text] [Related]
9. Subtype-specific expression and genetic alterations of the chemokinereceptor gene CXCR4 in medulloblastomas.
Schüller U; Koch A; Hartmann W; Garrè ML; Goodyer CG; Cama A; Sörensen N; Wiestler OD; Pietsch T
Int J Cancer; 2005 Oct; 117(1):82-9. PubMed ID: 15880586
[TBL] [Abstract][Full Text] [Related]
10. Targeting the enhancer of zeste homologue 2 in medulloblastoma.
Alimova I; Venkataraman S; Harris P; Marquez VE; Northcott PA; Dubuc A; Taylor MD; Foreman NK; Vibhakar R
Int J Cancer; 2012 Oct; 131(8):1800-9. PubMed ID: 22287205
[TBL] [Abstract][Full Text] [Related]
11. Human medulloblastomas lack point mutations and homozygous deletions of the hSNF5/INI1 tumour suppressor gene.
Kraus JA; Oster C; Sörensen N; Berthold F; Schlegel U; Tonn JC; Wiestler OD; Pietsch T
Neuropathol Appl Neurobiol; 2002 Apr; 28(2):136-41. PubMed ID: 11972800
[TBL] [Abstract][Full Text] [Related]
12. Robust molecular subgrouping and copy-number profiling of medulloblastoma from small amounts of archival tumour material using high-density DNA methylation arrays.
Hovestadt V; Remke M; Kool M; Pietsch T; Northcott PA; Fischer R; Cavalli FM; Ramaswamy V; Zapatka M; Reifenberger G; Rutkowski S; Schick M; Bewerunge-Hudler M; Korshunov A; Lichter P; Taylor MD; Pfister SM; Jones DT
Acta Neuropathol; 2013 Jun; 125(6):913-6. PubMed ID: 23670100
[No Abstract] [Full Text] [Related]
13. Adult and pediatric medulloblastomas are genetically distinct and require different algorithms for molecular risk stratification.
Korshunov A; Remke M; Werft W; Benner A; Ryzhova M; Witt H; Sturm D; Wittmann A; Schöttler A; Felsberg J; Reifenberger G; Rutkowski S; Scheurlen W; Kulozik AE; von Deimling A; Lichter P; Pfister SM
J Clin Oncol; 2010 Jun; 28(18):3054-60. PubMed ID: 20479417
[TBL] [Abstract][Full Text] [Related]
14. Proteomic analysis of Medulloblastoma reveals functional biology with translational potential.
Rivero-Hinojosa S; Lau LS; Stampar M; Staal J; Zhang H; Gordish-Dressman H; Northcott PA; Pfister SM; Taylor MD; Brown KJ; Rood BR
Acta Neuropathol Commun; 2018 Jun; 6(1):48. PubMed ID: 29880060
[TBL] [Abstract][Full Text] [Related]
15. G9a/EHMT2 is a Potential Prognostic Biomarker and Molecular Target in SHH Medulloblastoma.
Souza BK; Freire NH; Jaeger M; de Farias CB; Brunetto AL; Brunetto AT; Roesler R
Neuromolecular Med; 2022 Dec; 24(4):392-398. PubMed ID: 35113321
[TBL] [Abstract][Full Text] [Related]
16. Medulloblastomics: the end of the beginning.
Northcott PA; Jones DT; Kool M; Robinson GW; Gilbertson RJ; Cho YJ; Pomeroy SL; Korshunov A; Lichter P; Taylor MD; Pfister SM
Nat Rev Cancer; 2012 Dec; 12(12):818-34. PubMed ID: 23175120
[TBL] [Abstract][Full Text] [Related]
17. Analysis of the Max-binding protein MNT in human medulloblastomas.
Sommer A; Waha A; Tonn J; Sörensen N; Hurlin PJ; Eisenman RN; Lüscher B; Pietsch T
Int J Cancer; 1999 Sep; 82(6):810-6. PubMed ID: 10446446
[TBL] [Abstract][Full Text] [Related]
18. FoxG1 interacts with Bmi1 to regulate self-renewal and tumorigenicity of medulloblastoma stem cells.
Manoranjan B; Wang X; Hallett RM; Venugopal C; Mack SC; McFarlane N; Nolte SM; Scheinemann K; Gunnarsson T; Hassell JA; Taylor MD; Lee C; Triscott J; Foster CM; Dunham C; Hawkins C; Dunn SE; Singh SK
Stem Cells; 2013 Jul; 31(7):1266-77. PubMed ID: 23592496
[TBL] [Abstract][Full Text] [Related]
19. Preponderance of sonic hedgehog pathway activation characterizes adult medulloblastoma.
Al-Halabi H; Nantel A; Klekner A; Guiot MC; Albrecht S; Hauser P; Garami M; Bognar L; Kavan P; Gerges N; Shirinian M; Roberge D; Muanza T; Jabado N
Acta Neuropathol; 2011 Feb; 121(2):229-39. PubMed ID: 21107850
[TBL] [Abstract][Full Text] [Related]
20. Mismatch repair deficiency: a temozolomide resistance factor in medulloblastoma cell lines that is uncommon in primary medulloblastoma tumours.
von Bueren AO; Bacolod MD; Hagel C; Heinimann K; Fedier A; Kordes U; Pietsch T; Koster J; Grotzer MA; Friedman HS; Marra G; Kool M; Rutkowski S
Br J Cancer; 2012 Oct; 107(8):1399-408. PubMed ID: 22976800
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
